| abstract |
The present invention relates to deuterated 1-piperazino-3-phenyl-indane and salts thereof having activity at central nervous system dopamine receptors D1 and D2 and 5HT2 receptors, pharmaceuticals containing such compounds as active ingredients, The use of such compounds in the treatment of diseases of the central nervous system, as well as therapeutic methods involving the administration of such compounds. |